Prognostic Value of lncRNA DRAIC and miR-3940-3p in Lung Adenocarcinoma and Their Effect on Lung Adenocarcinoma Cell Progression
Zhenghua Liu, Shize Yang, Siyu Zhou, Shiyao Dong, Jiang Du Department of Thoracic Surgery, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning Province, People’s Republic of ChinaCorrespondence: Jiang DuDepartment of Thoracic Surgery, The First Affiliated Hospital o...
Enregistré dans:
Auteurs principaux: | Liu Z, Yang S, Zhou S, Dong S, Du J |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8e2f75411e7e4601a7e6e6cbbbfccb95 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Four long noncoding RNAs act as biomarkers in lung adenocarcinoma
par: Zhang Zhihui, et autres
Publié: (2021) -
LncRNA ADAMTS9-AS2 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lung Adenocarcinoma
par: Lin Z, et autres
Publié: (2021) -
Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma
par: Guojun Lu, et autres
Publié: (2021) -
Identification of Six Prognostic Genes in EGFR–Mutant Lung Adenocarcinoma Using Structure Network Algorithms
par: Haomin Zhang, et autres
Publié: (2021) -
Development of a Prognostic Nomogram for Patients with Lung Adenocarcinoma in the Stages I, II, and III Based on Immune Scores
par: Xie H, et autres
Publié: (2021)